The search result changed since you submitted your search request. Documents might be displayed in a different sort order.
  • search hit 31 of 56768
Back to Result List

Three-dimensional cell culture approach for in vitro immunization and the production of monoclonal antibodies

  • The generation of monoclonal antibodies using an in vitro immunization approach is a promising alternative to conventional hybridoma technology. As recently published, the in vitro approach enables an antigen-specific activation of B lymphocytes within 10-12 d followed by immortalization and subsequent selection of hybridomas. This in vitro process can be further improved by using a three-dimensional surrounding to stabilize the complex microenvironment required for a successful immune reaction. In this study, the suitability of Geltrex as a material for the generation of monoclonal antigen-specific antibodies by in vitro immunization was analyzed. We could show that dendritic cells, B cells, and T cells were able to travel through and interact inside of the matrix, leading to the antigen-specific activation of T and B cells. For cell recovery and subsequent hybridoma technique the suitability of dispase and Corning cell recovery solution (CRS) was compared. In our experiments, the use of dispase resulted in a severe alteration ofThe generation of monoclonal antibodies using an in vitro immunization approach is a promising alternative to conventional hybridoma technology. As recently published, the in vitro approach enables an antigen-specific activation of B lymphocytes within 10-12 d followed by immortalization and subsequent selection of hybridomas. This in vitro process can be further improved by using a three-dimensional surrounding to stabilize the complex microenvironment required for a successful immune reaction. In this study, the suitability of Geltrex as a material for the generation of monoclonal antigen-specific antibodies by in vitro immunization was analyzed. We could show that dendritic cells, B cells, and T cells were able to travel through and interact inside of the matrix, leading to the antigen-specific activation of T and B cells. For cell recovery and subsequent hybridoma technique the suitability of dispase and Corning cell recovery solution (CRS) was compared. In our experiments, the use of dispase resulted in a severe alteration of cell surface receptor expression patterns and significantly higher cell death, while we could not detect an adverse effect of Corning CRS. Finally, an easy approach for high-density cell culture was established by printing an alginate ring inside a cell culture vessel. The ring was filled with Geltrex, cells, and medium to ensure a sufficient supply during cultivation. Using this approach, we were able to generate monoclonal hybridomas that produce antigen-specific antibodies against ovalbumin and the SARS-CoV-2 nucleocapsid protein.show moreshow less

Export metadata

Additional Services

Search Google Scholar Statistics
Metadaten
Author details:Robert EngelORCiD, Burkhard Micheel, Katja HanackORCiDGND
DOI:https://doi.org/10.1088/1748-605X/ac7b00
ISSN:1748-6041
ISSN:1748-605X
Pubmed ID:https://pubmed.ncbi.nlm.nih.gov/35728755
Title of parent work (English):Biomedical materials : materials for tissue engineering and regenerative medicine
Publisher:Inst. of Physics
Place of publishing:London
Publication type:Article
Language:English
Date of first publication:2022/07/04
Publication year:2022
Release date:2023/01/25
Tag:3D; Geltrex; cell culture; hybridoma technology; in vitro immunization; monoclonal antibody
Volume:17
Issue:5
Article number:055003
Number of pages:11
Funding institution:Helmholtz Graduate School for Macromolecular Bioscience [VH-GS-503]
Organizational units:Mathematisch-Naturwissenschaftliche Fakultät / Institut für Biochemie und Biologie
DDC classification:6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Peer review:Referiert
Publishing method:Open Access / Hybrid Open-Access
License (German):License LogoCC-BY - Namensnennung 4.0 International
Accept ✔
This website uses technically necessary session cookies. By continuing to use the website, you agree to this. You can find our privacy policy here.